Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Clinical trial NCT06331702 · COMPLETED

Trial details

NCT number: NCT06331702
Sponsor: Liaoning Chengda Biotechnology CO., LTD
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Japanese Encephalitis Measles Mumps Rubella

Start date: 2024-03-02
Primary completion: 2025-02-11
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.